Press Releases

Albuquerque, NM and Seoul, South Korea – 25 April 2023 – Indica Labs, an industry leader in quantitative digital pathology and image management innovations, and Lunit, a leading medical AI software platform company focused on cancer biomarkers announced an agreement to provide a fully interoperable solution between Indica Labs’ HALO AP® image management software platform and Lunit’s suite of AI pathology products. The combined solution is already in use at Guardant Health, a leading precision oncology company.

Albuquerque, USA and Eindhoven, The Netherlands – April 17th, 2023 – Xyall and Indica Labs have entered into a global strategic partnership designed to bridge the gap between histology and molecular pathology. It unites Xyall’s unique automated tissue dissection solutions with Indica Labs’ AI-powered, diagnostic digital pathology platform. 

Albuquerque, NM and Hamamatsu City, Japan, – 14th October 2022 – Indica Labs, an industry leader in quantitative digital pathology and image management solutions, and Hamamatsu Photonics K.K., a forerunner in whole slide imaging systems, announced an agreement to maintain long-term interoperability between Indica Labs’ HALO AP® software platform and Hamamatsu’s NanoZoomer family of high-speed, high-resolution scanners.

Vista, CA – Sep 4, 2022, Leica Biosystems, a cancer diagnostics company and a global leader in workflow solutions, and Indica Labs, the industry-leading provider of computational and image management software in digital pathology, today announced a partnership focused on delivering compatible digital pathology workflow solutions.

Albuquerque, NM, and Glasgow, Scotland, – 30 August, 2022 – Indica Labs, an industry leader in quantitative digital pathology and image management solutions, and The Industrial Centre for Artificial Intelligence Research in Digital Diagnostics (iCAIRD), announced today an agreement to collaborate on the development of an AI-based digital pathology solution for the detection of cancer within lymph nodes from colorectal surgery cases.

Seoul, South Korea, and Albuquerque, NM – August 9, 2022 – Deep Bio, a company concentrating on SaMD (Software as a Medical Device) for digital pathology, is offering clinically validated, AI-based DeepDx® algorithms, and Indica Labs, a leading provider of computational pathology software and services, are excited to announce the successful integration of the DeepDx® Prostate algorithm into the HALO AP® platform from Indica Labs.

ALBUQUERQUE, NM – May 24, 2022 – Indica Labs, the leading provider of computational pathology software and services, is excited to announce a CE-IVD Mark for HALO Prostate AI, a deep learning-based screening tool designed to assist pathologists in identifying and grading prostate cancer in core needle biopsies.